Pharmaceutical dosage form comprising 4 - [(2R) - 6.7 - dihydro - 5h pyrrolo [1,2-c] imidazole - 5 - yl] - 3 - fluorobenzonitrilo or a Salt thereof and at least 30% microcrystalline Cellulose; Preparation procedure; used to treat Cushing's Syndrome.
Pharmaceutical dosage form comprising 4 - [(2R) - 6.7 - dihydro - 5h pyrrolo [1,2-c] imidazole - 5 - yl] - 3 - fluorobenzonitrilo or a Salt thereof and at least 30% microcrystalline Cellulose; Preparation procedure; used to treat Cushing's Syndrome.FORMA DE DOSIFICACIÓN FARMACÉUTICA QUE COMPRENDE 4-[(5R)-6,7-DIHIDRO-5H-PIRROLO[1,2-C]IMIDAZOL-5-IL]-3-FLUOROBENZONITRILO O UNA SAL DEL MISMO Y AL MENOS 30% DE CELULOSA MICROCRISTALINA; PROCEDIMIENTO DE PREPARACIÓN; USO PARA TRATAR EL SÍNDROME DE CUSHING.